カテゴリ： 世界, 医療/バイオ, QYResearch

医療用経皮パッチの世界市場2023年：サリチル酸メチル系パッチ、ジクロフェナクパッチ、ニコチン経皮パッチ、その他

■ 英語タイトル：Global Medical Transdermal Patch Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8129）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8129
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：103
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[医療用経皮パッチの世界市場2023年：サリチル酸メチル系パッチ、ジクロフェナクパッチ、ニコチン経皮パッチ、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は医療用経皮パッチのグローバル市場について調査・分析し、世界の医療用経皮パッチ市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（サリチル酸メチル系パッチ、ジクロフェナクパッチ、ニコチン経皮パッチ、その他）、用途別セグメント分析（Rxチャンネル、OTCチャンネル）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Hisamitsu Pharmaceutical、Johnson & Johnson、Novartis、UCB Pharma、Mylan、Teva Pharmaceutical、Nitto Denko、Grunenthal、IBSA Group、GSK、Luye Pharma Group、Pfizer、Chattem、Bayer、Mundipharma、Endo International、Beijing Tide Pharmaceuticalなどが含まれています。医療用経皮パッチのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、医療用経皮パッチ市場規模を算出する際に考慮しました。

・医療用経皮パッチ市場の概要
- 製品の定義
- 医療用経皮パッチの種類別セグメント
- 世界の医療用経皮パッチ市場規模：タイプ別分析（サリチル酸メチル系パッチ、ジクロフェナクパッチ、ニコチン経皮パッチ、その他）
- 医療用経皮パッチの用途別セグメント
- 世界の医療用経皮パッチ市場規模：用途別分析（Rxチャンネル、OTCチャンネル）
- 世界の医療用経皮パッチ市場規模予測（2018年-2029年）
- 医療用経皮パッチの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 医療用経皮パッチ市場の競争状況およびトレンド

・医療用経皮パッチの地域別市場規模
- 北米の医療用経皮パッチ市場規模（2018年-2029年）
- 米国の医療用経皮パッチ市場規模（2018年-2029年）
- ヨーロッパの医療用経皮パッチ市場規模（2018年-2029年）
- アジア太平洋の医療用経皮パッチ市場規模（2018年-2029年）
- 中国の医療用経皮パッチ市場規模（2018年-2029年）
- 日本の医療用経皮パッチ市場規模（2018年-2029年）
- 韓国の医療用経皮パッチ市場規模（2018年-2029年）
- インドの医療用経皮パッチ市場規模（2018年-2029年）
- オーストラリアの医療用経皮パッチ市場規模（2018年-2029年）
- 中南米の医療用経皮パッチ市場規模（2018年-2029年）
- 中東・アフリカの医療用経皮パッチ市場規模（2018年-2029年）

・種類別セグメント：サリチル酸メチル系パッチ、ジクロフェナクパッチ、ニコチン経皮パッチ、その他
- 世界の医療用経皮パッチのタイプ別販売量（2018年-2023年）
- 世界の医療用経皮パッチのタイプ別売上（2018年-2023年）
- 世界の医療用経皮パッチのタイプ別価格

・用途別セグメント：Rxチャンネル、OTCチャンネル
- 世界の医療用経皮パッチの用途別販売量（2018年-2023年）
- 世界の医療用経皮パッチの用途別売上（2018年-2023年）
- 世界の医療用経皮パッチの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Hisamitsu Pharmaceutical、Johnson & Johnson、Novartis、UCB Pharma、Mylan、Teva Pharmaceutical、Nitto Denko、Grunenthal、IBSA Group、GSK、Luye Pharma Group、Pfizer、Chattem、Bayer、Mundipharma、Endo International、Beijing Tide Pharmaceutical

・産業チェーンと販売チャネルの分析
- 医療用経皮パッチ産業チェーン分析
- 医療用経皮パッチの主要原材料
- 医療用経皮パッチの販売チャネル
- 医療用経皮パッチのディストリビューター
- 医療用経皮パッチの主要顧客

・医療用経皮パッチ市場ダイナミクス
- 医療用経皮パッチの業界動向
- 医療用経皮パッチ市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Medical Transdermal Patch market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Medical Transdermal Patch is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Medical Transdermal Patch is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Medical Transdermal Patch include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grunenthal and IBSA Group, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical Transdermal Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Transdermal Patch.
The Medical Transdermal Patch market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Medical Transdermal Patch market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Transdermal Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grunenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
Segment by Type
Methyl Salicylate-based Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Segment by Application
Rx Channel
OTC Channel
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Transdermal Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medical Transdermal Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Medical Transdermal Patch Market Overview
1.1 Product Overview and Scope of Medical Transdermal Patch
1.2 Medical Transdermal Patch Segment by Type
1.2.1 Global Medical Transdermal Patch Market Value Comparison by Type (2023-2029)
1.2.2 Methyl Salicylate-based Patch
1.2.3 Diclofenac Patch
1.2.4 Nicotine Transdermal Patch
1.2.5 Others
1.3 Medical Transdermal Patch Segment by Application
1.3.1 Global Medical Transdermal Patch Market Value by Application: (2023-2029)
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Global Medical Transdermal Patch Market Size Estimates and Forecasts
1.4.1 Global Medical Transdermal Patch Revenue 2018-2029
1.4.2 Global Medical Transdermal Patch Sales 2018-2029
1.4.3 Global Medical Transdermal Patch Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Medical Transdermal Patch Market Competition by Manufacturers
2.1 Global Medical Transdermal Patch Sales Market Share by Manufacturers (2018-2023)
2.2 Global Medical Transdermal Patch Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Medical Transdermal Patch Average Price by Manufacturers (2018-2023)
2.4 Global Medical Transdermal Patch Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Medical Transdermal Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Transdermal Patch, Product Type & Application
2.7 Medical Transdermal Patch Market Competitive Situation and Trends
2.7.1 Medical Transdermal Patch Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Transdermal Patch Players Market Share by Revenue
2.7.3 Global Medical Transdermal Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Transdermal Patch Retrospective Market Scenario by Region
3.1 Global Medical Transdermal Patch Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Medical Transdermal Patch Global Medical Transdermal Patch Sales by Region: 2018-2029
3.2.1 Global Medical Transdermal Patch Sales by Region: 2018-2023
3.2.2 Global Medical Transdermal Patch Sales by Region: 2024-2029
3.3 Global Medical Transdermal Patch Global Medical Transdermal Patch Revenue by Region: 2018-2029
3.3.1 Global Medical Transdermal Patch Revenue by Region: 2018-2023
3.3.2 Global Medical Transdermal Patch Revenue by Region: 2024-2029
3.4 North America Medical Transdermal Patch Market Facts & Figures by Country
3.4.1 North America Medical Transdermal Patch Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Medical Transdermal Patch Sales by Country (2018-2029)
3.4.3 North America Medical Transdermal Patch Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Transdermal Patch Market Facts & Figures by Country
3.5.1 Europe Medical Transdermal Patch Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Medical Transdermal Patch Sales by Country (2018-2029)
3.5.3 Europe Medical Transdermal Patch Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Transdermal Patch Market Facts & Figures by Country
3.6.1 Asia Pacific Medical Transdermal Patch Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Medical Transdermal Patch Sales by Country (2018-2029)
3.6.3 Asia Pacific Medical Transdermal Patch Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Medical Transdermal Patch Market Facts & Figures by Country
3.7.1 Latin America Medical Transdermal Patch Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Medical Transdermal Patch Sales by Country (2018-2029)
3.7.3 Latin America Medical Transdermal Patch Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Transdermal Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Transdermal Patch Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Medical Transdermal Patch Sales by Country (2018-2029)
3.8.3 Middle East and Africa Medical Transdermal Patch Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Transdermal Patch Sales by Type (2018-2029)
4.1.1 Global Medical Transdermal Patch Sales by Type (2018-2023)
4.1.2 Global Medical Transdermal Patch Sales by Type (2024-2029)
4.1.3 Global Medical Transdermal Patch Sales Market Share by Type (2018-2029)
4.2 Global Medical Transdermal Patch Revenue by Type (2018-2029)
4.2.1 Global Medical Transdermal Patch Revenue by Type (2018-2023)
4.2.2 Global Medical Transdermal Patch Revenue by Type (2024-2029)
4.2.3 Global Medical Transdermal Patch Revenue Market Share by Type (2018-2029)
4.3 Global Medical Transdermal Patch Price by Type (2018-2029)
5 Segment by Application
5.1 Global Medical Transdermal Patch Sales by Application (2018-2029)
5.1.1 Global Medical Transdermal Patch Sales by Application (2018-2023)
5.1.2 Global Medical Transdermal Patch Sales by Application (2024-2029)
5.1.3 Global Medical Transdermal Patch Sales Market Share by Application (2018-2029)
5.2 Global Medical Transdermal Patch Revenue by Application (2018-2029)
5.2.1 Global Medical Transdermal Patch Revenue by Application (2018-2023)
5.2.2 Global Medical Transdermal Patch Revenue by Application (2024-2029)
5.2.3 Global Medical Transdermal Patch Revenue Market Share by Application (2018-2029)
5.3 Global Medical Transdermal Patch Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Hisamitsu Pharmaceutical
6.1.1 Hisamitsu Pharmaceutical Corporation Information
6.1.2 Hisamitsu Pharmaceutical Description and Business Overview
6.1.3 Hisamitsu Pharmaceutical Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Hisamitsu Pharmaceutical Medical Transdermal Patch Product Portfolio
6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Johnson & Johnson Medical Transdermal Patch Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Novartis Medical Transdermal Patch Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 UCB Pharma
6.4.1 UCB Pharma Corporation Information
6.4.2 UCB Pharma Description and Business Overview
6.4.3 UCB Pharma Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.4.4 UCB Pharma Medical Transdermal Patch Product Portfolio
6.4.5 UCB Pharma Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Mylan Medical Transdermal Patch Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Corporation Information
6.6.2 Teva Pharmaceutical Description and Business Overview
6.6.3 Teva Pharmaceutical Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Teva Pharmaceutical Medical Transdermal Patch Product Portfolio
6.6.5 Teva Pharmaceutical Recent Developments/Updates
6.7 Nitto Denko
6.6.1 Nitto Denko Corporation Information
6.6.2 Nitto Denko Description and Business Overview
6.6.3 Nitto Denko Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Nitto Denko Medical Transdermal Patch Product Portfolio
6.7.5 Nitto Denko Recent Developments/Updates
6.8 Grunenthal
6.8.1 Grunenthal Corporation Information
6.8.2 Grunenthal Description and Business Overview
6.8.3 Grunenthal Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Grunenthal Medical Transdermal Patch Product Portfolio
6.8.5 Grunenthal Recent Developments/Updates
6.9 IBSA Group
6.9.1 IBSA Group Corporation Information
6.9.2 IBSA Group Description and Business Overview
6.9.3 IBSA Group Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.9.4 IBSA Group Medical Transdermal Patch Product Portfolio
6.9.5 IBSA Group Recent Developments/Updates
6.10 GSK
6.10.1 GSK Corporation Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.10.4 GSK Medical Transdermal Patch Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Luye Pharma Group
6.11.1 Luye Pharma Group Corporation Information
6.11.2 Luye Pharma Group Medical Transdermal Patch Description and Business Overview
6.11.3 Luye Pharma Group Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Luye Pharma Group Medical Transdermal Patch Product Portfolio
6.11.5 Luye Pharma Group Recent Developments/Updates
6.12 Pfizer
6.12.1 Pfizer Corporation Information
6.12.2 Pfizer Medical Transdermal Patch Description and Business Overview
6.12.3 Pfizer Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Pfizer Medical Transdermal Patch Product Portfolio
6.12.5 Pfizer Recent Developments/Updates
6.13 Chattem
6.13.1 Chattem Corporation Information
6.13.2 Chattem Medical Transdermal Patch Description and Business Overview
6.13.3 Chattem Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Chattem Medical Transdermal Patch Product Portfolio
6.13.5 Chattem Recent Developments/Updates
6.14 Bayer
6.14.1 Bayer Corporation Information
6.14.2 Bayer Medical Transdermal Patch Description and Business Overview
6.14.3 Bayer Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Bayer Medical Transdermal Patch Product Portfolio
6.14.5 Bayer Recent Developments/Updates
6.15 Mundipharma
6.15.1 Mundipharma Corporation Information
6.15.2 Mundipharma Medical Transdermal Patch Description and Business Overview
6.15.3 Mundipharma Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Mundipharma Medical Transdermal Patch Product Portfolio
6.15.5 Mundipharma Recent Developments/Updates
6.16 Endo International
6.16.1 Endo International Corporation Information
6.16.2 Endo International Medical Transdermal Patch Description and Business Overview
6.16.3 Endo International Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Endo International Medical Transdermal Patch Product Portfolio
6.16.5 Endo International Recent Developments/Updates
6.17 Beijing Tide Pharmaceutical
6.17.1 Beijing Tide Pharmaceutical Corporation Information
6.17.2 Beijing Tide Pharmaceutical Medical Transdermal Patch Description and Business Overview
6.17.3 Beijing Tide Pharmaceutical Medical Transdermal Patch Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Beijing Tide Pharmaceutical Medical Transdermal Patch Product Portfolio
6.17.5 Beijing Tide Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Transdermal Patch Industry Chain Analysis
7.2 Medical Transdermal Patch Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Transdermal Patch Production Mode & Process
7.4 Medical Transdermal Patch Sales and Marketing
7.4.1 Medical Transdermal Patch Sales Channels
7.4.2 Medical Transdermal Patch Distributors
7.5 Medical Transdermal Patch Customers
8 Medical Transdermal Patch Market Dynamics
8.1 Medical Transdermal Patch Industry Trends
8.2 Medical Transdermal Patch Market Drivers
8.3 Medical Transdermal Patch Market Challenges
8.4 Medical Transdermal Patch Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Medical Transdermal Patch Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Medical Transdermal Patch Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Medical Transdermal Patch Market Competitive Situation by Manufacturers in 2022
Table 4. Global Medical Transdermal Patch Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Medical Transdermal Patch Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Medical Transdermal Patch Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Medical Transdermal Patch Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Medical Transdermal Patch Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Medical Transdermal Patch, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Medical Transdermal Patch, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Medical Transdermal Patch, Product Type & Application
Table 12. Global Key Manufacturers of Medical Transdermal Patch, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Medical Transdermal Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Transdermal Patch as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Medical Transdermal Patch Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Medical Transdermal Patch Sales by Region (2018-2023) & (K Units)
Table 18. Global Medical Transdermal Patch Sales Market Share by Region (2018-2023)
Table 19. Global Medical Transdermal Patch Sales by Region (2024-2029) & (K Units)
Table 20. Global Medical Transdermal Patch Sales Market Share by Region (2024-2029)
Table 21. Global Medical Transdermal Patch Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Medical Transdermal Patch Revenue Market Share by Region (2018-2023)
Table 23. Global Medical Transdermal Patch Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Medical Transdermal Patch Revenue Market Share by Region (2024-2029)
Table 25. North America Medical Transdermal Patch Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Medical Transdermal Patch Sales by Country (2018-2023) & (K Units)
Table 27. North America Medical Transdermal Patch Sales by Country (2024-2029) & (K Units)
Table 28. North America Medical Transdermal Patch Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Medical Transdermal Patch Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Medical Transdermal Patch Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Medical Transdermal Patch Sales by Country (2018-2023) & (K Units)
Table 32. Europe Medical Transdermal Patch Sales by Country (2024-2029) & (K Units)
Table 33. Europe Medical Transdermal Patch Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Medical Transdermal Patch Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Medical Transdermal Patch Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Medical Transdermal Patch Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Medical Transdermal Patch Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Medical Transdermal Patch Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Medical Transdermal Patch Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Medical Transdermal Patch Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Medical Transdermal Patch Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Medical Transdermal Patch Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Medical Transdermal Patch Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Medical Transdermal Patch Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Medical Transdermal Patch Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Medical Transdermal Patch Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Medical Transdermal Patch Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Medical Transdermal Patch Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Medical Transdermal Patch Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Medical Transdermal Patch Sales (K Units) by Type (2018-2023)
Table 51. Global Medical Transdermal Patch Sales (K Units) by Type (2024-2029)
Table 52. Global Medical Transdermal Patch Sales Market Share by Type (2018-2023)
Table 53. Global Medical Transdermal Patch Sales Market Share by Type (2024-2029)
Table 54. Global Medical Transdermal Patch Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Medical Transdermal Patch Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Medical Transdermal Patch Revenue Market Share by Type (2018-2023)
Table 57. Global Medical Transdermal Patch Revenue Market Share by Type (2024-2029)
Table 58. Global Medical Transdermal Patch Price (US$/Unit) by Type (2018-2023)
Table 59. Global Medical Transdermal Patch Price (US$/Unit) by Type (2024-2029)
Table 60. Global Medical Transdermal Patch Sales (K Units) by Application (2018-2023)
Table 61. Global Medical Transdermal Patch Sales (K Units) by Application (2024-2029)
Table 62. Global Medical Transdermal Patch Sales Market Share by Application (2018-2023)
Table 63. Global Medical Transdermal Patch Sales Market Share by Application (2024-2029)
Table 64. Global Medical Transdermal Patch Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Medical Transdermal Patch Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Medical Transdermal Patch Revenue Market Share by Application (2018-2023)
Table 67. Global Medical Transdermal Patch Revenue Market Share by Application (2024-2029)
Table 68. Global Medical Transdermal Patch Price (US$/Unit) by Application (2018-2023)
Table 69. Global Medical Transdermal Patch Price (US$/Unit) by Application (2024-2029)
Table 70. Hisamitsu Pharmaceutical Corporation Information
Table 71. Hisamitsu Pharmaceutical Description and Business Overview
Table 72. Hisamitsu Pharmaceutical Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Hisamitsu Pharmaceutical Medical Transdermal Patch Product
Table 74. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 75. Johnson & Johnson Corporation Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Johnson & Johnson Medical Transdermal Patch Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Novartis Medical Transdermal Patch Product
Table 84. Novartis Recent Developments/Updates
Table 85. UCB Pharma Corporation Information
Table 86. UCB Pharma Description and Business Overview
Table 87. UCB Pharma Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. UCB Pharma Medical Transdermal Patch Product
Table 89. UCB Pharma Recent Developments/Updates
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Mylan Medical Transdermal Patch Product
Table 94. Mylan Recent Developments/Updates
Table 95. Teva Pharmaceutical Corporation Information
Table 96. Teva Pharmaceutical Description and Business Overview
Table 97. Teva Pharmaceutical Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Teva Pharmaceutical Medical Transdermal Patch Product
Table 99. Teva Pharmaceutical Recent Developments/Updates
Table 100. Nitto Denko Corporation Information
Table 101. Nitto Denko Description and Business Overview
Table 102. Nitto Denko Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Nitto Denko Medical Transdermal Patch Product
Table 104. Nitto Denko Recent Developments/Updates
Table 105. Grunenthal Corporation Information
Table 106. Grunenthal Description and Business Overview
Table 107. Grunenthal Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Grunenthal Medical Transdermal Patch Product
Table 109. Grunenthal Recent Developments/Updates
Table 110. IBSA Group Corporation Information
Table 111. IBSA Group Description and Business Overview
Table 112. IBSA Group Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. IBSA Group Medical Transdermal Patch Product
Table 114. IBSA Group Recent Developments/Updates
Table 115. GSK Corporation Information
Table 116. GSK Description and Business Overview
Table 117. GSK Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. GSK Medical Transdermal Patch Product
Table 119. GSK Recent Developments/Updates
Table 120. Luye Pharma Group Corporation Information
Table 121. Luye Pharma Group Description and Business Overview
Table 122. Luye Pharma Group Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Luye Pharma Group Medical Transdermal Patch Product
Table 124. Luye Pharma Group Recent Developments/Updates
Table 125. Pfizer Corporation Information
Table 126. Pfizer Description and Business Overview
Table 127. Pfizer Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Pfizer Medical Transdermal Patch Product
Table 129. Pfizer Recent Developments/Updates
Table 130. Chattem Corporation Information
Table 131. Chattem Description and Business Overview
Table 132. Chattem Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Chattem Medical Transdermal Patch Product
Table 134. Chattem Recent Developments/Updates
Table 135. Bayer Corporation Information
Table 136. Bayer Description and Business Overview
Table 137. Bayer Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Bayer Medical Transdermal Patch Product
Table 139. Bayer Recent Developments/Updates
Table 140. Mundipharma Corporation Information
Table 141. Mundipharma Description and Business Overview
Table 142. Mundipharma Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Mundipharma Medical Transdermal Patch Product
Table 144. Mundipharma Recent Developments/Updates
Table 145. Endo International Corporation Information
Table 146. Endo International Description and Business Overview
Table 147. Endo International Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Endo International Medical Transdermal Patch Product
Table 149. Endo International Recent Developments/Updates
Table 150. Beijing Tide Pharmaceutical Corporation Information
Table 151. Beijing Tide Pharmaceutical Description and Business Overview
Table 152. Beijing Tide Pharmaceutical Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Beijing Tide Pharmaceutical Medical Transdermal Patch Product
Table 154. Beijing Tide Pharmaceutical Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Medical Transdermal Patch Distributors List
Table 158. Medical Transdermal Patch Customers List
Table 159. Medical Transdermal Patch Market Trends
Table 160. Medical Transdermal Patch Market Drivers
Table 161. Medical Transdermal Patch Market Challenges
Table 162. Medical Transdermal Patch Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Medical Transdermal Patch
Figure 2. Global Medical Transdermal Patch Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Medical Transdermal Patch Market Share by Type in 2022 & 2029
Figure 4. Methyl Salicylate-based Patch Product Picture
Figure 5. Diclofenac Patch Product Picture
Figure 6. Nicotine Transdermal Patch Product Picture
Figure 7. Others Product Picture
Figure 8. Global Medical Transdermal Patch Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Medical Transdermal Patch Market Share by Application in 2022 & 2029
Figure 10. Rx Channel
Figure 11. OTC Channel
Figure 12. Global Medical Transdermal Patch Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Medical Transdermal Patch Market Size (2018-2029) & (US$ Million)
Figure 14. Global Medical Transdermal Patch Sales (2018-2029) & (K Units)
Figure 15. Global Medical Transdermal Patch Average Price (US$/Unit) & (2018-2029)
Figure 16. Medical Transdermal Patch Report Years Considered
Figure 17. Medical Transdermal Patch Sales Share by Manufacturers in 2022
Figure 18. Global Medical Transdermal Patch Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Medical Transdermal Patch Players: Market Share by Revenue in 2022
Figure 20. Medical Transdermal Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Medical Transdermal Patch Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Medical Transdermal Patch Sales Market Share by Country (2018-2029)
Figure 23. North America Medical Transdermal Patch Revenue Market Share by Country (2018-2029)
Figure 24. United States Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Medical Transdermal Patch Sales Market Share by Country (2018-2029)
Figure 27. Europe Medical Transdermal Patch Revenue Market Share by Country (2018-2029)
Figure 28. Germany Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Medical Transdermal Patch Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Medical Transdermal Patch Revenue Market Share by Region (2018-2029)
Figure 35. China Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Medical Transdermal Patch Sales Market Share by Country (2018-2029)
Figure 45. Latin America Medical Transdermal Patch Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Medical Transdermal Patch Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Medical Transdermal Patch Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Medical Transdermal Patch Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Medical Transdermal Patch by Type (2018-2029)
Figure 55. Global Revenue Market Share of Medical Transdermal Patch by Type (2018-2029)
Figure 56. Global Medical Transdermal Patch Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Medical Transdermal Patch by Application (2018-2029)
Figure 58. Global Revenue Market Share of Medical Transdermal Patch by Application (2018-2029)
Figure 59. Global Medical Transdermal Patch Price (US$/Unit) by Application (2018-2029)
Figure 60. Medical Transdermal Patch Value Chain
Figure 61. Medical Transdermal Patch Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の経皮皮膚パッチ市場2022年：市場規模予測（～2028年）
  • ヒアルロン酸マイクロニードルパッチの世界市場2023年：唇用、目元用
  • 美容用溶解性マイクロニードルパッチの世界市場2023年：マイクロニードルアクネパッチ、マイクロニードルアイパッチ、マイクロニードルマスク
  • にきびパッチの世界市場2023年：ハイドロコロイド素材、再生プラスチック素材
  • 世界のオキシブチニン経皮システム市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8129 )"医療用経皮パッチの世界市場2023年：サリチル酸メチル系パッチ、ジクロフェナクパッチ、ニコチン経皮パッチ、その他" (英文：Global Medical Transdermal Patch Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。